FDA Warns About Counterfeit Versions of Diabetes Drug Ozempic
The U.S. Food and Drug Administration on Thursday warned consumers not to use counterfeit versions of Novo Nordisk’s diabetes drug Ozempic that have been found in the country’s drug supply chain. The health regulator said that it would continue to investigate counterfeit Ozempic 1-milligram injections and had seized thousands of units, but that some might … Read more
